India’s Pharma Supply Chain: Building Resilience Through Local Manufacturing
Explore how India is strengthening pharmaceutical supply chain resilience through API localization, CDMO partnerships, and diversified manufacturing.
Introduction
Global pharmaceutical supply chains are adapting to changing trade policies, geopolitical uncertainty, logistics challenges, and rising operational costs. These developments have increased the importance of supply chain resilience, diversified sourcing, and reliable manufacturing partnerships. India’s established pharmaceutical ecosystem and growing CDMO sector position it to contribute to more diversified global supply networks.
Strengthening India’s Pharmaceutical Supply Chain
Dependence on a limited number of sources for active pharmaceutical ingredients (APIs) and key starting materials (KSMs) can expose manufacturers to supply disruptions. Expanding domestic production, developing alternative suppliers, and improving procurement visibility can help reduce these risks. India’s manufacturing infrastructure and initiatives to support domestic production create opportunities to strengthen the pharmaceutical supply chain.
The Role of CDMOs and Technology
Contract Development and Manufacturing Organizations (CDMOs) support pharmaceutical companies through development, technology transfer, scale-up, and commercial manufacturing. Partnerships with experienced CDMOs can provide access to specialized infrastructure and help companies diversify manufacturing networks. Digital procurement, data analytics, and improved inventory visibility can further support planning and operational continuity.
Biodeal Pharmaceuticals: Supporting India’s Manufacturing Ecosystem
Biodeal Pharmaceuticals Limited is an India-based CDMO with manufacturing capabilities across pharmaceutical and nutraceutical dosage forms, including injectables, nasal sprays, dry powder inhalers, tablets, capsules, and sachets. Its manufacturing network includes facilities in Baddi, Paonta Sahib, and Nalagarh. As companies explore diversified manufacturing partnerships, CDMOs such as Biodeal form part of the ecosystem supporting pharmaceutical production and supply chain flexibility.
Looking Ahead
Building resilient pharmaceutical supply chains requires diversified sourcing, capable manufacturing partners, quality-focused operations, and better supply chain visibility. With continued investment in infrastructure, technology, and domestic capabilities, India can further strengthen its role in global pharmaceutical manufacturing.
About Biodeal Pharmaceuticals Limited
Biodeal Pharmaceuticals Limited is an India-based Contract Development and Manufacturing Organization (CDMO) supporting pharmaceutical and nutraceutical businesses. Learn more at www.biodealpharma.com or contact sales@biodealpharma.com.
Further Reading
Read the original ETPharma article: Pharma Supply Chains in Flux: Navigating Tariffs, Trade and Geopolitics